shutterstock_57369385

NHS suppliers investigated over 1000% price hikes

pharmafile | October 26, 2016 | News story | Research and Development, Sales and Marketing |  NHS, price hikes 

The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs have risen in price by 1,000% in five years.

Health secretary Jeremy Hunt called in the CMA when an investigation by The Times revealed that drugmakers could be exploiting a loophole in NHS legislation to hike the prices of their products, facing limited competition on long-established, off-patent drugs, bought from large pharmaceutical firms.

The CMA said: “The investigation relates to suspected unfair pricing by way of charging excessive prices in the supply of certain pharmaceutical products, including to the National Health Service.”

Advertisement

If found guilty, companies could be fined up to 10% of their turnover.

Concordia International said it was one of the companies being investigated. A spokesman said: “We are working co-operatively to better understand the CMA’s position and we will continue to work constructively to resolve the matter.

“Although Concordia has also had past discussions with the CMA regarding the supply of certain of its products in the UK, this is the first interaction with the CMA regarding the company’s pricing.”

Incidentally, Concordia have made the news recently as it was revealed its CEO has resigned, allegedly in connection with the company’s history of aggressively hiking the prices of a number of its products.

Matt Fellows

Related Content

“That gap between innovation and delivery was what stood out to me most”

Pharmafile chats with Camunda’s Natosha McNeal about the vital role of delivery, onboarding AI and …

Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study

People in their forties account for almost three-quarters of those who do not attend NHS …

NIHR chief scientific adviser visits Huddersfield health innovation campus

Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health and Social Care and …

The Gateway to Local Adoption Series

Latest content




Five Facts about COPD

October 11, 2026